Desktop Site
|
28 Mar 24 | 16:00
|
Close
Equity
SME
Eq Drv
Currency
Commodity
Corporates
Watch List
Get Quote
Notices
|
S&P
BSE SENSEX
73,651.35
+655.04
+0.90 %
Corporate Announcement
Security Code
531146
Company
MEDICAMEN BIOTECH LTD.-$
Exchange Received Time
29/05/2020 16:35:47
Exchange Disseminated Time
29/05/2020 16:35:52
Time Taken
00:00:05
Format of Initial Disclosure to be made by an entity identified as a Large Corporate |
5/29/2020 4:35:47 PM
Format of Initial Disclosure to be made by an entity identified as a Large Corporate.
Sr. No.
Particulars
Details
1
Name of Compay
MEDICAMEN BIOTECH LTD.-$
2
CIN
L74899DL1993PLC056594
3
Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr)
23582607.00
4
Highest Credit Rating during the previous FY
BBB-
4a
Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)
CRISIL LTD.
5
Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the framework
BSE
We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No
Name of the Company Secretary: Parul Choudhary
Designation: Company Secretary and Compliance Officer
EmailId: cs@medicamen.com
Name of the Chief Financial Officer: Pratap Singh Rawat
Designation: Chief Financial Officer
EmailId: cfo@medicamen.com
Date: 29/05/2020
Note:
In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
Attachment
<< Back
Recently Viewed